دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
The challenge of cardiovascular prevention in the elderly: importance of randomized clinical trials
Filippo Crea
doi : 10.1093/eurheartj/ehac273
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 1997–2000
Preventing stroke in atrial fibrillation patients
Mark Nicholls
doi : 10.1093/eurheartj/ehac019
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 2001–2002
Smart devices resulting in big effect: can apps cure heart disease? How hybrid care may revolutionize heart disease treatment
Irina Eckardt, Philip Düsing, Georg Nickenig, Felix Jansen
doi : 10.1093/eurheartj/ehab917
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 2003–2004
A training project to promote clinical research among young cardiologists
Stefania Angela Di Fusco, Aldo Pietro Maggioni, Furio Colivicchi
doi : 10.1093/eurheartj/ehac074
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 2005–2007
The DISCHARGE trial: imaging a new strategy for the clinical management of stable chest pain?
Rocco Vergallo, Massimo Volpe
doi : 10.1093/eurheartj/ehac193
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 2008–2009
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
Sarah Parish, Marion Mafham, Alison Offer, Jill Barton, Karl Wallendszus, William Stevens, Georgina Buck, Richard Haynes, Rory Collins, Louise Bowman, Jane Armitage
doi : 10.1093/eurheartj/ehac179
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 2010–2019
Aspirin is widely used in cardiovascular disease prevention but is also associated with an increased risk of bleeding. The net effect of aspirin on dementia and cognitive impairment is uncertain.
The end of aspirin for dementia prevention in diabetes?
Steen D Kristensen, Kevin K W Olesen, Michael Maeng
doi : 10.1093/eurheartj/ehac211
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 2020–2022
Polypill for prevention of cardiovascular diseases with focus on non-alcoholic steatohepatitis: the PolyIran-Liver trial
Shahin Merat, Elham Jafari, Amir Reza Radmard, Masoud Khoshnia, Maryam Sharafkhah, Alireza Nateghi Baygi, Tom Marshall, Abolfazl Shiravi Khuzani, Kar Keung Cheng, Hossein Poustchi, Reza Malekzadeh
doi : 10.1093/eurheartj/ehab919
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 2023–2033
Individuals with non-alcoholic steatohepatitis or elevated liver enzymes have increased cardiovascular mortality but are often excluded from prevention trials. We investigated the effectiveness of fixed-dose combination therapy for the prevention of major cardiovascular events (MCVE) among individuals with and without presumed non-alcoholic steatohepatitis (pNASH).
A polypill for cardiovascular disease prevention with a focus on non-alcohol steatohepatitis
Philip Joseph, Salim Yusuf
doi : 10.1093/eurheartj/ehac029
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 2034–2036
Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study
Pier D Lambiase, Dominic A Theuns, Francis Murgatroyd, Craig Barr, Lars Eckardt, Petr Neuzil, Marcoen Scholten, Margaret Hood, JÈ•rgen Kuschyk, Amy J Brisben, Nathan Carter, Timothy M Stivland, Reinoud Knops, Lucas V A Boersma
doi : 10.1093/eurheartj/ehab921
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 2037–2050
To report 5-year outcomes of EFFORTLESS registry patients with early generation subcutaneous implantable cardioverter-defibrillator (S-ICD) devices.
Long-term results of first-generation S-ICD systems: strong from the start and through the threats of time
Riccardo Cappato
doi : 10.1093/eurheartj/ehac137
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 2051–2053
Effect of a multi-domain lifestyle intervention on cardiovascular risk in older people: the FINGER trial
Jenni Lehtisalo, Minna Rusanen, Alina Solomon, Riitta Antikainen, Tiina Laatikainen, Markku Peltonen, Timo Strandberg, Jaakko Tuomilehto, Hilkka Soininen, Miia Kivipelto, Tiia Ngandu
doi : 10.1093/eurheartj/ehab922
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 2054–2061
Joint prevention of cardiovascular disease (CVD) and dementia could reduce the burden of both conditions. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) demonstrated a beneficial effect on cognition (primary outcome) and we assessed the effect of this lifestyle intervention on incident CVD (pre-specified secondary outcome).
Pointing a FINGER at the contribution of lifestyle to cardiovascular events and dementia
Michel Noutsias, Michael Hauptmann, Heinz Völler
doi : 10.1093/eurheartj/ehac186
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 2062–2064
Effect of 5 years of exercise training on the cardiovascular risk profile of older adults: the Generation 100 randomized trial
Jon Magne Letnes, Ida Berglund, Kristin E Johnson, Håvard Dalen, Bjarne M Nes, Stian Lydersen, Hallgeir Viken, Erlend Hassel, Sigurd Steinshamn, Elisabeth Kleivhaug Vesterbekkmo, Asbjørn Støylen, Line S Reitlo, Nina Zisko, Fredrik H Bækkerud, Atefe R Tari, Jan Erik Ingebrigtsen, Silvana B Sandbakk, Trude Carlsen, Sigmund A Anderssen, Maria A Fiatarone Singh, Jeff S Coombes, Jorunn L Helbostad, Øivind Rognmo, Ulrik Wisløff, Dorthe Stensvold
doi : 10.1093/eurheartj/ehab721
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 2065–2075
The aim of this study was to compare the effects of 5 years of supervised exercise training (ExComb), and the differential effects of subgroups of high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT), with control on the cardiovascular risk profile in older adults.
Encouraging physical activity amongst older adults; where should we stand?
Mai-Lis Hellénius
doi : 10.1093/eurheartj/ehab872
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Pages 2076–2077,
Left main bifurcation treatment: is one stent enough?
W K den Dekker, K D Mahmoud, E Boersma
doi : 10.1093/eurheartj/ehac078
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Page 2078
The stepwise provisional approach to left main stem bifurcations in Europe
David Hildick-Smith
doi : 10.1093/eurheartj/ehac080
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Page 2079
Transcatheter mitral valve in ring implantation: a word of caution based on histopathological workup
Martin O Schmiady, Thierry Carrel, Matthias Sigler, Katja Eildermann
doi : 10.1093/eurheartj/ehac032
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Page 2080,
Transcatheter lithotripsy to facilitate post-dilatation of underexpanded aortic transcatheter heart valve
Igor Belluschi, Nicola Buzzatti, Paolo Denti, Francesco Maisano
doi : 10.1093/eurheartj/ehac044
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Page 2081
Corrigendum to: Incidence, Risk Factors and Mortality of Atrial Fibrillation in Breast Cancer: A SEER-Medicare Analysis
doi : 10.1093/eurheartj/ehac012
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Page 201
Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
doi : 10.1093/eurheartj/ehac051
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Page 2022
Corrigendum to: Nudging within learning health systems: next generation decision support to improve cardiovascular care
doi : 10.1093/eurheartj/ehac098
European Heart Journal, Volume 43, Issue 21, 1 June 2022, Page 2033
